Neurotrophic and Neuroprotective Actions of Ginsenosides Rb1 and Rg1
The DOI matches its Crossref record.
Abstract
The ginsenosides have many pharmacological actions, including various actions on the nervous system. Our previous studies have demonstrated that two ginsenosides, Rb(1) and Rg(1) improve performance in a passive avoidance-learning paradigm and enhance cholinergic metabolism. The present study was designed to examine the cellular neurotrophic and neuroprotective actions of two pure ginsenosides in two model systems. PC12 cells were grown in the absence or presence of nerve growth factor (NGF) as a positive control, and different concentrations of Rb(1) or Rg(1). To assess neurotrophic properties, neurite outgrowth was quantified for representative fields of cells. After 8 days in culture, both ginsenosides enhanced neurite outgrowth in the presence of a sub-optimal dose of (2 ng/ml) NGF, but did not significantly stimulate neurite outgrowth in the absence of NGF. However, after 18 days in culture, both ginsenosides increased neurite outgrowth in the absence of NGF. SN-K-SH cells were grown in the absence or presence of MPTP or beta-amyloid to assess neuroprotection. Rb(1) and Rg(1) both reversed MPTP-induced cell death. beta-Amyloid-induced cell death was not reversed by either ginsenoside, but Rg(1) produced a modest enhancement of cell death in this model. These results suggest that these two ginsenosides have neurotrophic and selective neuroprotective actions that may contribute to the purported enhancement of cognitive function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The biological action of saponins in animal systems: a review
Francis, G., Kerem, Z., Makkar, H. P. S., & Becker, K. (2002) · British Journal of Nutrition · doi:10.1079/bjn2002725 · Cited by 1,720
Ma, R., Sun, L., Chen, X., Mei, B., Chang, G., Wang, M., & Zhao, D. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.00001 · Cited by 1,503
Pharmacology of ginsenosides: a literature review
Leung, K., & Wong, A. (2010) · Chinese Medicine · doi:10.1186/1749-8546-5-20 · Cited by 537
Christensen (2008) · doi:10.1016/s1043-4526(08)00401-4 · Cited by 504
Neuritic regeneration and synaptic reconstruction induced by withanolide A
Kuboyama, T., Tohda, C., & Komatsu, K. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706122 · Cited by 339
“…physiological substances such as cholesterol (Fan et al., 2002) and estradiol (Cambiasso & Carrer, 2001; Audesirk et al., 2003), and isolated compounds from herbal drugs such as genipin (Yamazaki et al., 2001), ginsenoside Rb1 (Rudakewich et al., 2001), nardosinone (Li et al., 1999) were reported.”
BackgroundUse of Ginseng in Medicine With Emphasis on Neurodegenerative Disorders
Radad, K., Gille, G., Liu, L., & Rausch, W.-D. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj05010x · Cited by 265
Venkatesan, R., Ji, E., & Kim, S. Y. (2015) · BioMed Research International · doi:10.1155/2015/814068 · Cited by 212
Withanoside IV and its active metabolite, sominone, attenuate Aβ(25–35)‐induced neurodegeneration
Kuboyama, T., Tohda, C., & Komatsu, K. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04664.x · Cited by 171
“Although many groups have described compounds that promote neurite outgrowth (Li et al., 1999; Rudakewich et al., 2001; Yamazaki et al., 2001; Li et al., 2002), we have attached greater importance to activity of recovering from Ab(25–35)-induced neuritic and synaptic damage (Kuboyama et al., 2005;…”
BackgroundEffect of wild ginseng on scopolamine-induced acetylcholine depletion in the rat hippocampus
Lee, B., Park, J., Kwon, S., Park, M.-W., Oh, S.-M., Yeom, M.-J., Shim, I., Lee, H.-J., & Hahm, D.-H. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.62.02.0015 · Cited by 40
Metadata
- Authors
- Rudakewich, M., Ba, F., & Benishin, C.
- Venue
- Planta Medica
- Publisher
- Georg Thieme Verlag KG
- Published
- 2001-08-17
- Volume
- 67
- Issue
- 06
- Pages
- 533-537
- ISSN
- 0032-0943 (ISSN-L)
- 1439-0221
- OpenAlex
- W1978747281
- Cited by
- 124
- References
- 0
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.